C35H41N5O5
Neat
611.75
Dihydroergocristine; 9, 10-Dihydroergocristine; 17479-19-5; DHEC; GNF-Pf-3462; 05D48LUM4Z; DTXSID3046322; DTXCID1026322; CHEBI:59912; Erotaman-3', 6', 18-trione, 9, 10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha, 10alpha)-; (10alphaH)-5'alpha-benzyl-12'-hydroxy-3', 6', 18-trioxo-2'-(propan-2-yl)-9, 10-dihydroergotaman; RefChem:133803; N-(7-benzyl-2-hydroxy-5, 8-dioxo-4-(propan-2-yl)-3-oxa-6, 9-diazatricyclo(7.3.0.0^(2, 6))dodecan-4-yl)-6-methyl-6, 11-diazatetracyclo(7.6.1.0^(2, 7).0^(12, 16))hexadeca-1(16), 9, 12, 14-tetraene-4-carboxamide; 241-493-4; Ergotaman-3', 6', 18-trione, 9, 10alpha-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(phenylmethyl)-; Dihydroergocristin; CHEMBL601773; (6aR, 9R, 10aR)-N-[(1S, 2S, 4R, 7S)-7-benzyl-2-hydroxy-5, 8-dioxo-4-propan-2-yl-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9, 10, 10a-hexahydro-4H-indolo[4 and 3-fg]quinoline-9-carboxamide; NCGC00017401-02; CAS-17479-19-5
(6aR, 9R, 10aR)-N-[(1S, 2S, 4R, 7S)-7-benzyl-2-hydroxy-5, 8-dioxo-4-propan-2-yl-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9, 10, 10a-hexahydro-4H-indolo[4 and 3-fg]quinoline-9-carboxamide
InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)/t23-,25-,27-,28+,29+,34-,35+/m1/s1